Parham Jabbarzadeh Kaboli,  PhD
Parham Jabbarzadeh Kaboli, PhD
Assistant Professor of Pharmacology, School of Pharmacy, Southwest Medical University, China
Verified email at parhamscience.com - Homepage
TitleCited byYear
Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer
P Jabbarzadeh Kaboli, A Rahmat, P Ismail, KH Ling
European Journal of Pharmacology 740, 584-595, 2014
812014
MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment
PJ Kaboli, A Rahmat, P Ismail, KH Ling
Pharmacological research 97, 104-121, 2015
772015
An ethnobotanical survey of medicinal plants used by indigenous people in Zangelanlo district, Northeast Iran
MS Amiri, P Jabbarzadeh, M Akhondi
Journal of Medicinal Plants Research 6 (5), 749-753, 2012
312012
Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: A new group of RAF inhibitors for cancer treatment
PJ Kaboli, P Ismail, KH Ling
PloS one 13 (3), e0193941, 2018
52018
Molecular modelling of berberine derivatives as inhibitors of human smoothened receptor and hedgehog signalling pathway using a newly developed algorithm on anti-cancer drugs
PJ Kaboli, M Bazrafkan, P Ismail, KH Ling
Recent patents on anti-cancer drug discovery 12 (4), 384-400, 2017
52017
Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study
PJ Kaboli, MPY Leong, P Ismail, KH Ling
Pharmacological Reports 71 (1), 13-23, 2019
42019
PIK3CA rs7640662 (C/G) single nucleotide polymorphism lacks association with breast cancer cases in Persians
A Mir, M Sadegh, Z Ahmadinia, P Jabbarzadeh Kaboli
Interventional Medicine and Applied Science 7 (1), 3-8, 2015
32015
Floristic study of Zangelanlo watershed (Khorassan, Iran)
MS AMIRI, P JABBARZADEH
JOURNAL OF TAXONOMY AND BIOSISTEMATICS 2 (5), 1-15, 2011
32011
A novel one-click automated drug discovery tool: a new approach based on binding efficiency indices
PJ Kaboli, M Bazrafkan, P Ismail, KH Ling
The FASEB Journal 31 (1_supplement), 818.7-818.7, 2017
22017
Berberine Derivatives as Multi-Kinase Inhibitors of MAP Kinase and PI3K Pathways: Molecular Modelling, Molecular Dynamics Simulations, and in vitro Evaluation
PJ Kaboli, P Ismail, KH Ling
The FASEB Journal 31 (1_supplement), 671.12-671.12, 2017
12017
m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer
Y Zhao, Q Zhao, PJ Kaboli, J Shen, M Li, X Wu, J Yin, H Zhang, Y Wu, ...
Translational oncology 12 (10), 1323-1333, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–11